NOV 28, 2015 10:56 AM PST

Functional Human Liver Cells Successfully Grown in Lab

WRITTEN BY: Julianne Chiaet
A group of German and Israeli scientists have successfully grown human liver cells in the laboratory that did not lose their metabolic function.  

The cells, called hepatocytes, make up about 80 percent of the liver’s mass. The human liver is the only organ that has the ability to rapidly regenerate lost tissue. As little as 25 percent of a liver can regenerate into a whole liver.

Unfortunately, hepatocytes lose their regenerative ability when removed from the body. Scientists who previously tried to tackle the problem ended up with cancer cells with little metabolic function. This inability has been a major obstacle for scientific, clinical and pharmaceutical development.
Fluorescently labeled polarized Upcyte® hepatocytes.

The scientists based their research on the German Cancer Research Center’s early work on HPV. They demonstrated that weak expression of Human Papilloma Virus (HPV) E6 and E7 proteins released hepatocytes from cell-cycle arrest, a stopping point in the cell cycle. The expression allowed the released hepatocytes to rapidly increase in response to Oncostatin M (OSM), a protein important in liver regeneration. Thus, the stimulation of OSM caused the cells to rapidly multiply.

They were careful to select colonies of human hepatocytes that only rapidly multiplied in response to OSM. The cells doubling time was 33 to 49 hours. Removal of OSM caused the cell to stop growing and, within 4 days, become highly functional liver cells. The method, called the upcyte© process, allows the cells to double 35 times since their primary isolation in the lab; resulting in approximately 1015 quadrillion cells from each liver isolation.

The strength of method lies in its ability to generate liver cells from multiple donors of ethnically diverse backgrounds, said biochemist Joris Braspenning, who led the German group. "[It enables] the study of patient-to-patient variability and idiosyncratic toxicity."

“Our technology will enable thousands of laboratories to study fatty liver disease, viral hepatitis, drug toxicity and liver cancer at a fraction of the current cost,” lead author and biomedical engineer Yaakov Nahmias said. The pharmaceutical industry routinely uses human hepatocytes when studying the major problem of hepatotoxicity, liver damage caused by a chemical or medicine. It is the most common reason for a drug to be withdrawn from the market. The development could additionally advance creating bio-artificial liver support for patients awaiting transplantations. 

The study was published online on October 26, 2015, by the journal Nature Biotechnology.

Source: The Hebrew University of Jerusalem via Science Daily
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to
You May Also Like
MAY 07, 2020
MAY 07, 2020
Yet Another Cancer Linked Tyrosine Kinase
In a cell, there are tens of thousands of individual components. Each component has a specific activity or role that the ...
MAY 06, 2020
MAY 06, 2020
The Brain Replays Waking Experiences While You Sleep
Researchers have found that while we sleep, our brains are busy processing our waking experiences. A process called &lsq ...
MAY 07, 2020
Health & Medicine
MAY 07, 2020
Mosquito Feeding Time Shift Impacts Malaria Prevention Methods
Thanks to the success of insecticide-treated bed nets, mosquitos seem to have shifted their feeding times away from the ...
MAY 12, 2020
Genetics & Genomics
MAY 12, 2020
Learning More About Why Some Diseases Have a Sex Bias
The biological differences between men and women go beyond the things we're aware of like the sex chromosomes and hormon ...
MAY 26, 2020
MAY 26, 2020
An App That Detects Retinal Damage
The most common cause of blindness in working-age adults is retinal damage as a result of diabetes. To address this prob ...
JUN 06, 2020
JUN 06, 2020
Developing a Platform to Efficiently Test Antibody-Drug Conjugates
Cancer has been one of the most persistent diseases modern medicine has faced. Due to its nature, treatments are often t ...
Loading Comments...